Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

Vaccine
Judith Del CampoAli M Harandi

Abstract

The purpose of this study was to investigate the potential of intranasal (IN) immunization with Neisseria meningitides B proteoliposome (AFPL1) and AFPL1-derived cochleate (AFCo1), containing glycoprotein D (gD) of herpes simplex virus type 2 (HSV-2) for induction of protective immunity against genital herpes infection in mice. We could show that IN immunization with both AFPL1 and AFCo1 containing gD induced gD-specific IgG antibody and lymphoproliferative responses. However, IFN-gamma response could only be detected in CD4(+) splenic cells and genital lymph node cells of the AFCo1gD immunized mice upon recall antigen stimulation in vitro. Importantly, IN immunization with AFCo1gD could elicit a complete protection against an otherwise lethal vaginal challenge with HSV-2, while the AFPL1gD immunized mice were only partially protected. Further, we could show that the IFN-gamma response and protective immunity observed after IN immunization with AFCo1gD are mediated via the adaptor molecule myeloid differentiation factor 88. These data may have implications for the development of a mucosal vaccine against genital herpes.

References

Feb 12, 1998·Journal of Reproductive Immunology·M B Parr, E L Parr
Jul 22, 1998·Journal of Immunological Methods·R M MartinA M Lew
Apr 9, 1999·Vaccine·D I Bernstein, L R Stanberry
Jan 15, 2003·Clinical Microbiology Reviews·David M Koelle, Lawrence Corey
Jan 31, 2004·Seminars in Immunology·Kiyoshi Takeda, Shizuo Akira
Jul 11, 2006·Vaccine·Caridad ZayasOliver Pérez
Apr 26, 2007·Nature Reviews. Immunology·Luke A J O'Neill, Andrew G Bowie
Jul 20, 2007·Scandinavian Journal of Immunology·O PérezC Campa
Oct 13, 2007·Expert Review of Vaccines·Manmohan SinghDerek O'Hagan

❮ Previous
Next ❯

Citations

Dec 19, 2013·PloS One·Elena PettiniDonata Medaglini
Mar 2, 2011·Canadian Journal of Microbiology·Belkis RomeuOliver Pérez
May 17, 2011·Cellular and Molecular Life Sciences : CMLS·Raquel F EpandRichard M Epand
Aug 28, 2012·Nature Biotechnology·Frank WegmannQuentin J Sattentau
Nov 16, 2012·Expert Review of Vaccines·Ayman GebrilValerie A Ferro
May 13, 2010·Expert Opinion on Drug Delivery·Béatrice HeurtaultFrançoise Pons
Dec 19, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Tamás BozóMiklós S Z Kellermayer
Mar 2, 2011·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Eder Lilia Romero, Maria Jose Morilla
Apr 9, 2016·Oncoimmunology·Shee Eun LeeJoon Haeng Rhee
Jun 19, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jamie F S MannRobin J Shattock
Jul 4, 2015·Canadian Journal of Microbiology·Elizabeth González AznarOliver Pérez
Aug 14, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F AnjuèreC Luci
Oct 30, 2016·Biochimie·Zahra KakhiFrançoise Pons
Mar 8, 2012·Reviews in Medical Virology·Erin Chung, Jonathan Sen
Sep 29, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiuli ZhangLbachir Benmohamed
Apr 26, 2019·The Science of the Total Environment·Beatriz Tamargo SantosV Gustavo Sierra González
Sep 16, 2021·Expert Review of Vaccines·Myron ChristodoulidesJohn E Heckels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.